Depression in premenopausal women: Gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 4, 2003, Pages 705-709

  Rajewska, Jolanta ^a   Rybakowski, Janusz K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

D fenfluramine challenge test; Depression; Gonadal hormones; Menopausal symptoms; Perimenopause; Serotonin

Indexed keywords

DEXFENFLURAMINE; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; PROLACTIN; SEROTONIN; SEX HORMONE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GONAD; HAMILTON SCALE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MEASUREMENT; MENOPAUSE; ONSET AGE; PREMENOPAUSE; PROVOCATION TEST; PSYCHOMETRY; RECURRENT DISEASE; SAMPLE; SEROTONINERGIC SYSTEM; SYMPTOM;

EID: 0037674666     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00085-X     Document Type: Article

References (31)

1. Avis N.E., Brambilla D., McKinlay S.M., Vass K. A longitudinal analysis of the association between menopause and depression - results from the Massachusetts Women's Health Study. Ann. Epidemiol. 4:1994;214-220.
2. Beck A.T., Ward C.H., Mendelsohn M. An inventory for measuring depression. Arch. Gen. Psychiatry. 4:1961;561-571.
3. Berendsen H.H. The role of serotonin in hot flushes. Maturitas. 36:2000;155-164.
4. Bosworth H.B., Bastian L.A., Kuchibhatla M.N., Steffens D.C., McBride C.M., Skinner C.S., Rimer B.K., Siegler I.C. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom. Med. 63:2001;603-608.
5. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynaecol. 4:1977;31-47.
6. Cleare A.J., Bearn J., Allain T., McGregor A., Wessely S., Murray R.M., O'Keane V. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J. Affect. Disord. 35:1995;283-289.
7. Coope J. Is oestrogen therapy effective in the treatment of menopausal depression? J. R. Coll. Gen. Pract. 31:1981;134-140.
8. Correa H., Duval F., Mokrani M., Bailey P., Tremenau F., Staner L., Diep T.S., Hode Y., Crocq M.A., Macher J.P. Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res. 93:2000;189-199.
9. Diagnostic and Statistical Manual of Mental Disorders DSM-IV. 4th ed. 1994;American Psychiatric Association, Washington, DC.
10. Dinan T., O'Keane V. Reply to letter 'Elevated cortisol concentrations and the diminished prolactin response to fenfluramine' by Mitchell, PB, Smyther, GA. Am. J. Psychiatry. 149:1992;851-852.
11. Duval F., Mokrani M.C., Correa H., Bailey P., Valdebenito M., Monreal J., Crocq M.A., Macher J.P. Lack of effect of HPA axis hyperactivity on hormonal responses to D-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology. 26:2001;521-537.
12. Fava M., Vuolo R.D., Wright E.C., Nierenberg A.A., Alpert J.E., Rosenbaum J.F. Fenfluramine challenge in unipolar depression with and without anger attacks. Psychiatry Res. 94:2000;9-18.
13. FitzGerald M., Malone K., Li S., Harrison W.M., McBride P.A., Endicott J., Cooper T., Mann J.J. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. Am. J. Psychiatry. 54:1997;556-558.
14. Guicheney P., Léger D., Barrat J., Trévoux R., De Ligniéres B., Roques P. Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms. Eur. J. Clin. Invest. 18:1988;297-304.
15. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
16. Harlow B.L., Wise L.A., Otto M.W., Soares C.N., Cohen L.S. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause. Arch. Gen. Psychiatry. 60:2003;29-36.
17. Joffe H., Cohen L.S. Estrogen, serotonin and mood disturbance: where is the therapeutic bridge? Biol. Psychiatry. 44:1998;798-811.
18. Kupperman H.S., Wetchler B.B., Blatt M.H.G. Contemporary therapy of the menopausal syndrome. J. Am. Med. Assoc. 171:1959;1627-1637.
19. Mitchell P.B., Smythe G.A. Hormonal responses to fenfluramine in depressed and control subjects. J. Affect. Disord. 19:1990;43-51.
20. Newman M.E., Shapira B., Lerer B. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. Int. J. Neuropsychopharmacol. 1:1998;49-69.
21. O'Keane V., Dinan T. Prolactin and cortisol responses to D-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am. J. Psychiatry. 148:1991;1009-1015.
22. O'Keane V., O'Hanlon M., Webb M., Dinan T. D-Fenfluramine/prolactin response through the menstrual cycle: evidence for an oestrogen-induced alteration. Clin. Endocrinol. 34:1991;289-292.
23. Rubinow D.R., Schmidt P.J., Roca C.A. Estrogen-serotonin interactions: implications for affective regulation. Biol. Psychiatry. 44:1998;839-850.
24. Schmidt P.J., Roca C.A., Bloch M., Rubinow D.R. The perimenopause and affective disorders. Semin. Reprod. Endocrinol. 15:1997;91-100.
25. Schmidt P.J., Nieman L., Danaceau M.A., Tobin M.B., Roca C.A., Murphy J.H., Rubinow D.R. Estrogen replacement in perimenopause-related depression: a preliminary report. Am. J. Obstet. Gynecol. 183:2000;414-420.
26. Schmidt P., Murphy J., Haq N., Danaceau M., St. Clair L. Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology. 27:2002;907.
27. Schneider M.A., Brotherton P.L., Hailes J. The effect of exogenous estrogens on depression in menopausal women. Med. J. Aust. 2:1977;162-163.
28. Schneider L.S., Small G.W., Hamilton S.H., Bystritsky A., Nemeroff C.B., Meyers B.S. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am. J. Geriatr. Psychiatry. 5:1997;97-106.
29. Soares C.N., Almeida O.P., Joffe H., Cohen L.S. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch. Gen. Psychiatry. 58:2001;529-534.
30. Young E.A., Midgley A.R., Carlson N.E., Brown M.B. Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch. Gen. Psychiatry. 57:2000;1157-1162.
31. Williams J.H.G. Using behavioural ecology to understand depression. Br. J. Psychiatry. 173:1998;453-454.